Leukocyte adhesion deficiency (LAD) is a rare, inherited disorder that affects the body’s ability to fight off infections. It is caused by a defect in the genes that code for proteins that are important for white blood cells to attach to the walls of blood vessels. As a result, patients with LAD have an impaired ability to fight off bacterial and fungal infections. The condition is usually diagnosed in infancy, although it can be diagnosed in children and adults. In this article, we will explore the causes and treatments of LAD.
LAD is caused by a genetic defect that affects the body’s ability to produce certain proteins that are important for the attachment of white blood cells to the walls of blood vessels. The defect is inherited in an autosomal recessive pattern, meaning that both parents must carry the defective gene for their child to be affected. The defective gene is located on chromosome 17 and is known as the CD18 gene. The CD18 gene is responsible for coding a protein called leukocyte adhesion molecule-1 (LAM-1). This protein is important for the attachment of white blood cells to the walls of blood vessels. Without this protein, white blood cells cannot attach to the walls of blood vessels, which impairs the body’s ability to fight off infections.
Patients with LAD typically experience recurrent bacterial and fungal infections. These infections can affect any part of the body, but are most common in the lungs, skin, and gastrointestinal tract. Patients may also experience delayed healing of wounds and ulcers, as well as frequent skin rashes. In addition, patients with LAD may experience severe anemia due to the body’s inability to produce enough white blood cells. This can lead to fatigue, paleness, and shortness of breath.
Diagnosis of LAD is typically made through a combination of clinical examination, laboratory tests, and genetic tests. During clinical examination, a doctor may look for signs of recurrent infections, delayed healing of wounds, and anemia. Laboratory tests can be used to measure white blood cell counts and to look for signs of infection. Genetic testing is the most reliable method for diagnosing LAD. This involves taking a sample of the patient’s blood or saliva and looking for the defective CD18 gene.
The primary treatment for LAD is antibiotics. These are used to treat any infections that the patient may have. In addition, patients may be prescribed antifungal medications to treat fungal infections. Patients may also be prescribed immunoglobulin therapy. This involves giving the patient injections of immunoglobulins, which are proteins produced by the body’s immune system. These proteins can help the body fight off infections. Finally, patients may be prescribed bone marrow transplantation. This involves taking healthy bone marrow from a donor and transplanting it into the patient. The healthy bone marrow can help the body produce enough white blood cells to fight off infections.
Leukocyte adhesion deficiency is a rare, inherited disorder that affects the body’s ability to fight off infections. It is caused by a defect in the genes that code for proteins that are important for white blood cells to attach to the walls of blood vessels. Patients with LAD typically experience recurrent bacterial and fungal infections, delayed healing of wounds, and anemia. Diagnosis of LAD is typically made through a combination of clinical examination, laboratory tests, and genetic tests. Treatment for LAD typically involves antibiotics, antifungal medications, immunoglobulin therapy, and bone marrow transplantation.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation